Norwegian committee to assess HCV (hepatitis C virus) infection
This article was originally published in Clinica
Executive Summary
Norwegian health minister Dagfinn Hoybraten has appointed a committee to investigate the health service and authorities handling of patients who may have been infected with the hepatitis C virus (HCV) through blood transfusions before 1994. The move comes after revelations earlier this spring that some 1,000-1,500 may have been infected before 1991 and that no efforts have as yet been made to locate them to offer them medical support.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.